US Surveillance of Acute Ischemic Stroke Patient Characteristics, Care Quality, and Outcomes for 2019

Abstract

BACKGROUND: The United States lacks a timely and accurate nationwide surveillance system for acute ischemic stroke (AIS). We use the Get With The Guidelines-Stroke registry to apply poststratification survey weights to generate national assessment of AIS epidemiology, hospital care quality, and in-hospital outcomes. METHODS: Clinical data from the Get With The Guidelines-Stroke registry were weighted using a Bayesian interpolation method anchored to observations from the national inpatient sample. To generate a US stroke forecast for 2019, we linearized time trend estimates from the national inpatient sample to project anticipated AIS hospital volume, distribution, and race/ethnicity characteristics for the year 2019. Primary measures of AIS epidemiology and clinical care included patient and hospital characteristics, stroke severity, vital and laboratory measures, treatment interventions, performance measures, disposition, and clinical outcomes at discharge. RESULTS: We estimate 552 476 patients with AIS were admitted in 2019 to US hospitals. Median age was 71 (interquartile range, 60–81), 48.8% female. Atrial fibrillation was diagnosed in 22.6%, 30.2% had prior stroke/transient ischemic attack, and 36.4% had diabetes. At baseline, 46.4% of patients with AIS were taking antiplatelet agents, 19.2% anticoagulants, and 46.3% cholesterol-reducers. Mortality was 4.4%, and only 52.3% were able to ambulate independently at discharge. Performance nationally on AIS achievement measures were generally higher than 95% for all measures but the use of thrombolytics within 3 hours of early stroke presentations (81.9%). Additional quality measures had lower rates of receipt: dysphagia screening (84.9%), early thrombolytics by 4.5 hours (79.7%), and statin therapy (80.6%). CONCLUSIONS: We provide timely, reliable, and actionable US national AIS surveillance using Bayesian interpolation poststratification weights. These data may facilitate more targeted quality improvement efforts, resource allocation, and national policies to improve AIS care and outcomes.

A 10-year review of antihypertensive prescribing practices after stroke and the associated disparities from the Florida Stroke Registry

“…We demonstrate that applying these Prescribers'-Choice Adherence Rules is feasible and could be used as new quality measures to improve compliance with post stroke guideline recommendations, for secondary stroke prevention. The use of quality measures to improve clinical practice is well accepted, and their benefits demonstrated by several programs such as the national American Heart Association GWTG-S quality improvement program which showed improved adherence to during hospitalization and after discharge [27][28][29][30] . These quality measures are now accepted as the standard of care by certifying organizations such as The Joint Commission and payers such as the Centers for Medicare and Medicaid.…”

Uncooperative patients suspected of acute stroke ineligible for prehospital stroke screening test by emergency medical service providers: final hospital diagnoses and characteristics

“…4 With its high prevalence and tremendous burden on society, prevention, diagnosis, treatment, and rehabilitation of stroke survivors are essential parts of the public health agenda. 5,6 Stroke is a time-sensitive emergency, and emergency medical services (EMS) transport up to 70% of patients with stroke. 7,8 To achieve optimal outcomes in patients with stroke, it is crucial to minimize the interval from symptom onset to definitive treatment to restore blood flow to the strokeaffected tissue.…”

In Search of Reliable and Complete Data on Stroke Severity: The Unfulfilled Promise of R29.7xx

“…Fortunately, the prevalence of NIHSS documentation in Get With The Guidelines–Stroke continues to improve; in one report from 2019 NIHSS was recorded in >90% of cases. 14…”